tirzepatide lawsuit Judge says compounding pharmacies must stop making copies of Zepbound, Mounjaro FDA's tirzepatide decision creates uncertainty

Results typically become visible after two to four months of consistent use

Obesity specialists routinely see patients respond differently to GLP-1 drugs, and some appear to achieve meaningful weight loss on lower doses than others

Kostic AD, Xavier RJ, Gevers D

Some women feel ready quickly

In most cases, these symptoms are mild and improve as your body adjusts, but they should not be ignored if they become persistent, severe, or occur with symptoms like chest pain or dizziness

Wegovy (semaglutide) is FDA-approved for chronic weight management in adults with obesity or overweight who have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol